Novakand Pharma AB
556806-8851ActiveDeveloping novel small-molecule drugs for inflammation and cancer.
Biotechnology Companynovakand.se
Yleiskatsaus
- 5–9
- Työntekijät
- ≤1t SEK
- Liikevaihto
- 2010
- Perustettu
Kuvaus
Novakand Pharma is a publicly listed biotechnology company operating out of the Karolinska Institutet Science Park in Solna, Sweden. The organization focuses on developing a novel class of innovative small-molecule drug candidates. Their primary therapeutic areas of focus are significant unmet medic...
Tunnisteet
B2BHealthcarePharmaceuticals
Avainsanat
BiotechDrug Development